0001638599-16-000925.txt : 20160525 0001638599-16-000925.hdr.sgml : 20160525 20160525163529 ACCESSION NUMBER: 0001638599-16-000925 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160524 FILED AS OF DATE: 20160525 DATE AS OF CHANGE: 20160525 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CorMedix Inc. CENTRAL INDEX KEY: 0001410098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1430 HIGHWAY 206 STREET 2: SUITE 200 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-517-9500 MAIL ADDRESS: STREET 1: 1430 HIGHWAY 206 STREET 2: SUITE 200 CITY: BEDMINSTER STATE: NJ ZIP: 07921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pfaffle Antony CENTRAL INDEX KEY: 0001368953 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34673 FILM NUMBER: 161675052 MAIL ADDRESS: STREET 1: C/O INNOVIVE PHARMACEUTICALS, INC. STREET 2: 555 MADISON AVENUE, 25TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 4 1 doc4_3979.xml PRIMARY DOCUMENT X0306 4 2016-05-24 0 0001410098 CorMedix Inc. CRMD 0001368953 Pfaffle Antony C/O CORMEDIX INC. 745 ROUTE 202-206, SUITE 303 BRIDGEWATER NJ 08807 1 1 0 0 Interim Chief Medical Officer Common Stock, $0.001 par value per share 2016-05-24 4 M 0 12700 0.68 A 12700 D Common Stock, $0.001 par value per share 2016-05-24 4 S 0 5000 2.7103 D 7700 D Common Stock, $0.001 par value per share 2016-05-24 4 S 0 5000 2.708 D 2700 D Common Stock, $0.001 par value per share 2016-05-24 4 S 0 2700 2.8015 D 0 D Stock Option (right to buy) 2.27 2024-04-01 Common Stock, $0.001 par value per share 100000 100000 D Stock Option (right to buy) 2.02 2024-01-09 Common Stock, $0.001 par value per share 100000 100000 D Stock Option (right to buy) 2.02 2024-01-09 Common Stock, $0.001 par value per share 30000 30000 D Stock Option (right to buy) 0.9 2023-03-22 Common Stock, $0.001 par value per share 210000 210000 D Stock Option (right to buy) 0.68 2016-05-24 4 M 0 12700 0 A 2022-12-05 Common Stock, $0.001 par value per share 162700 150000 D Stock Option (right to buy) 2.1 2021-01-14 Common Stock, $0.001 par value per share 30000 30000 D Stock Option (right to buy) 3.125 2020-03-30 Common Stock, $0.001 par value per share 20000 20000 D Stock Option (right to buy) 5 2025-02-24 Common Stock, $0.001 par value per share 75000 75000 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.76, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.70 to $2.72, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.80 to $2.82, inclusive. The options vested 100% on April 2, 2014. The options vested 100% on January 10, 2014. The options vest in full on the first anniversary of the date of grant. These options vest based on performance milestones running through December 31, 2014. These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013. These options vested on January 14, 2012. These options vested as follows: 1/3 on March 30, 2010; an additional 1/3 on March 30, 2011; and the remaining 1/3 on March 30, 2012. These options were granted on February 24, 2015, and vested immediately. Alexander M. Donaldson, with a Power of Attorney for Antony E. Pfaffle, M.D. 2016-05-25